Senior author and NYU Assistant Professor Dr Karan Chhabra on larger studies to address drug efficacy and who could do better ...

A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Mounjaro is set to be rolled out by the NHS in the UK this month but what are the key differences between that and Mounjaro ...

WEIGHT loss jabs, including Mounjaro and Wegovy, have been linked to more than 100 deaths in the UK, new figures have revealed. But none of the fatalities are proven to have been caused directly ...

General practitioners across the NHS are urging patients to cease requests for weight loss injections as they prepare for the ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and ...

WEIGHT loss jabs have been a godsend for people in the UK living with obesity. But despite 1.5 million people using the ...

Millions of Brits take weight loss jab to transform their waistlines. But who will be eligible to receive the potentially ...

Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir ...

Some blind vision loss cases have been linked to the use of weight-loss jabs, including Ozempic, so caution is recommended by ...

Tirzepatide, better known as Mounjaro, is a weight loss medication that helps you feel satiated for longer periods, thus reducing hunger pangs. The NHS explains that the drug works by "mimicking gut ...